Skip to content
Clinical Trials – home

Iaso Thessalia General Clinic Private Obstetrics S.A.

Research site

Greece 8th Km Old National Road Larissa-Athens, 410 00 Larissa, Greece

  • 2 trials recruiting
  • Breast cancer · Cardiac failure · Hormone receptor positive HER2 negative breast cancer
  • Adult patients

About Specializations

Iaso Thessalia General Clinic Private Obstetrics S.A. in Larissa, Greece specialises in clinical trials of conditions such as Breast cancer, Cardiac failure, Hormone receptor positive HER2 negative breast cancer, Hormone receptor positive breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Eye Diseases and Diagnostic Techniques

At Iaso Thessalia General Clinic Private Obstetrics S.A., research in ophthalmology focuses on glaucoma, ocular hypertension, and related eye conditions. These studies are designed to compare established and newer eye drop treatments, while also supporting better approaches to diagnosis and pupil dilation for clinical use.

  • Testing new generic eye drop combinations for open-angle glaucoma and ocular hypertension
  • Evaluating treatment effectiveness by measuring changes in intraocular pressure
  • Studying mydriatic eye drops to support pre-operative and diagnostic eye care

This area of research aims to improve everyday eye care by confirming whether alternative formulations can perform as well as reference treatments and help protect vision.

Cardiovascular Disease and Heart Failure

The site also supports research in cardiovascular diseases, with a focus on heart failure with preserved ejection fraction and heart failure with mildly reduced ejection fraction in people living with obesity. These trials are looking at whether a new therapy can lower the risk of serious heart-related events when added to standard care.

  • Studying heart failure outcomes in patients with obesity
  • Assessing whether treatment can reduce hospitalisation and urgent care visits
  • Comparing a new therapy with placebo alongside standard treatment

This work is aimed at improving long-term management of complex heart failure, especially where weight-related health issues may add to the burden of disease.

Autoimmune and Inflammatory Disease Research

Clinical research at the clinic also includes systemic lupus erythematosus, a chronic autoimmune disease that can affect multiple organs. The trial activity in this area is focused on evaluating a new treatment option to better control disease activity when used with standard care.

  • Investigating treatment effectiveness in systemic lupus erythematosus
  • Measuring changes in overall disease activity
  • Exploring whether a new therapy may improve care for patients with active disease

This research reflects an effort to expand options for people living with a complex autoimmune condition that often requires careful, ongoing management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
8th Km Old National Road Larissa-Athens410 00 LarissaGreece
Recruiting now
2 trials
Conditions studied
9

More sites in LarissaGreece

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Cardiac failure+1

Recruiting

Study of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:POLYPEPTIDE CONSISTING OF A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND AN AMYLIN RECEPTOR AGONIST, CONNECTED BY A LINKER WITH 4 GLYCINE RESIDUES, AND CONNECTED TO A C18 FATTY ACID SIDE CHAIN
  • Sponsor:Novo Nordisk A/S
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Brimonidine Tartrate
  • Sponsor:OmniVision GmbH

Breast cancer+2

Not recruiting

Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Celcuity Inc.

Mydriasis

Not recruiting

Study of eye drops containing tropicamide and phenylephrine hydrochloride for pupil dilation in healthy volunteers

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Sodium Chloride
  • Sponsor:Unither Pharmaceuticals

Open angle glaucoma+1

Not recruiting

Study Comparing Brimonidine and Timolol Eye Drops for Patients with Open-Angle Glaucoma or Ocular Hypertension

Registered drugNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Brimonidine Tartrate
  • Sponsor:Becro (Cyprus) Limited
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Brinzolamide
  • Sponsor:OmniVision GmbH

Study on Frexalimab for Treating Active Systemic Lupus Erythematosus in Patients

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.